http://www.lanternpharma.com
Lantern Pharma Inc. Company Intro
Lantern Pharma is a clinical stage oncology biotech that leverages Artificial Intelligence and Machine Learning to deeply understand genomic data.
Industry
Healthcare
Lantern Pharma Inc. Headquaters
1920 McKinney Avenue
Dallas,75201
United States
Lantern Pharma Inc. Share price
17 May 2023 13:29 GMT
$5.3600
0.06 (1.13 %)
Lantern Pharma Inc. Market cap
$51.571 M
WMC RANKING
2023
Lantern Pharma Inc. # 409
BiotechnologyLatest Lantern Pharma Inc. News
30 Nov 2023
2023-11-30 | NDAQ:LTRN | Press Release | Lantern Pharma Inc
FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in High-Grade B-cell Lymphomas (HGBL). LTRN | 12 hours ago. The Orphan Drug...
30 Nov 2023
Lantern Pharma: FDA Grants Orphan Drug Designation For ...
Lantern Pharma Inc. (LTRN) announced the FDA has granted LP-284 Orphan Drug Designation for the treatment of high-grade B-cell lymphoma with MYC and BCL2...
30 Nov 2023
FDA Grants Lantern Pharma Orphan Drug Designation for ...
This Orphan Drug Designation marks the second such designation for drug-candidate LP-284 this year. DALLAS--(BUSINESS WIRE)-- Lantern Pharma, Inc. (NASDAQ: LTRN)...
WMC Market Score
WMC Market to Revenue Score
Lantern Pharma Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Lantern Pharma Inc. | USD | $0 | $7,883 | $-7,883 | $516M | 409 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Lantern Pharma Inc. Social Followers vs Top 4 Industry Competitors
Lantern Pharma Inc. Post vs Top 4 Industry Competitors
Lantern Pharma Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Lantern Pharma Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Lantern Pharma Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Lantern Pharma Inc. | 0 | 0.66 | 0.02 | 0 | 0 | 0 | 0.29 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
